SLC22A6
Solute carrier family 22 member 6
Also known as: OAT1, PAHT, ROAT1, S22A6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4U2R8
- Gene
- SLC22A6
- Ensembl
- ENSG00000197901
- Chromosome
- 11
- Canonical length
- 563 aa
- Protein class
- FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene is involved in the sodium-dependent transport and excretion of organic anions, some of which are potentially toxic. The encoded protein is an integral membrane protein and may be localized to the basolateral membrane. Four transcript variants encoding four different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
563 residues, UniProt reviewed canonical sequence.
>Q4U2R8|SLC22A6
1 MAFNDLLQQV GGVGRFQQIQ VTLVVLPLLL MASHNTLQNF TAAIPTHHCR PPADANLSKN
61 GGLEVWLPRD RQGQPESCLR FTSPQWGLPF LNGTEANGTG ATEPCTDGWI YDNSTFPSTI
121 VTEWDLVCSH RALRQLAQSL YMVGVLLGAM VFGYLADRLG RRKVLILNYL QTAVSGTCAA
181 FAPNFPIYCA FRLLSGMALA GISLNCMTLN VEWMPIHTRA CVGTLIGYVY SLGQFLLAGV
241 AYAVPHWRHL QLLVSAPFFA FFIYSWFFIE SARWHSSSGR LDLTLRALQR VARINGKREE
301 GAKLSMEVLR ASLQKELTMG KGQASAMELL RCPTLRHLFL CLSMLWFATS FAYYGLVMDL
361 QGFGVSIYLI QVIFGAVDLP AKLVGFLVIN SLGRRPAQMA ALLLAGICIL LNGVIPQDQS
421 IVRTSLAVLG KGCLAASFNC IFLYTGELYP TMIRQTGMGM GSTMARVGSI VSPLVSMTAE
481 LYPSMPLFIY GAVPVAASAV TVLLPETLGQ PLPDTVQDLE SRWAPTQKEA GIYPRKGKQT
541 RQQQEHQKYM VPLQASAQEK NGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC22A6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 184 nTPM
Expression across tissuesHPA
Tissue
- kidney: 184 nTPM
- midbrain: 5.6 nTPM
- choroid plexus: 4.2 nTPM
- hypothalamus: 4.1 nTPM
- basal ganglia: 3.3 nTPM
- cerebral cortex: 2.2 nTPM
Single-cell type
- proximal tubule cells: 365 nCPM
- retinal pigment epithelial cells: 64 nCPM
- astrocytes: 16 nCPM
- renal connecting tubule cells: 8.1 nCPM
- distal convoluted tubule cells: 6.1 nCPM
- podocytes: 5.9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 19 nTPM
- medulla oblongata: 17 nTPM
- midbrain: 13 nTPM
- hypothalamus: 9.8 nTPM
- cerebellum: 9.7 nTPM
- spinal cord: 9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.58
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- alpha-ketoglutarate transport
- metanephric proximal tubule development
- monoatomic anion transport
- organic anion transport
- prostaglandin transport
- renal tubular secretion
- sodium-independent organic anion transport
Molecular functions
- alpha-ketoglutarate transmembrane transporter activity
- antiporter activity
- chloride ion binding
- identical protein binding
- organic anion transmembrane transporter activity
- prostaglandin transmembrane transporter activity
- sodium-independent organic anion transmembrane transporter activity
- solute:inorganic anion antiporter activity
- transmembrane transporter activity
- xenobiotic transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC22A6 as an antibody target. Whether an autoantibody or antibody against SLC22A6 could matter depends on whether native SLC22A6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC22A6 is annotated at the cell surface, where native SLC22A6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC22A6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...